Estradiol Patch Supply Strained in Salt Lake City

Patients may face difficulty filling prescriptions for hormone patches as local demand continues to increase.

Updated on Oct. 27, 2026 in Women’s Health

Gouache-painted illustration of a single medical hormone patch on a smooth stone, reflecting the quiet focus of menopause symptom management.
Pharmacies in Salt Lake City and across Utah are experiencing persistent shortages of estradiol patches as local demand for hormone therapy increases. AI Illustration. Upload story photo >

Live Poll

Do you feel confident that you can consistently access your necessary prescription medications?

Since May 2026, pharmacies in Salt Lake City and across Utah have faced persistent difficulty maintaining supply of estradiol patches. Patients managing menopause symptoms may face ongoing challenges filling prescriptions as demand continues to climb.

Why it matters

The supply strain stems from increased demand following the November 2025 removal of an FDA black box warning and October 2026 guidelines recommending hormone therapy for menopause. This shift has altered access for patients relying on transdermal estrogen for symptom management.

Manufacturers have reported a 50% increase in production of estradiol patches since 2025, yet this has not kept pace with a 167% rise in patient use over the past two years. Despite these figures, the medication is not currently on the official FDA national drug shortage list.

The players

Food and Drug Administration

The federal agency responsible for regulating medication safety, labeling, and monitoring the national drug supply.

The details

Estradiol patches function by delivering estrogen directly through the skin, providing a consistent hormonal dose. Because they are not currently listed as a formal shortage by federal regulators, inventory gaps often result in uneven regional availability. Patients in areas like Salt Lake City and Davis County have reported needing to contact multiple pharmacies to locate remaining stock or discussing alternative estrogen forms, such as tablets or creams, with their providers.

Timeline

  1. November 2025: The FDA removed the black box warning from estrogen products.

  2. May 2026: Local pharmacies began experiencing persistent back orders for patches.

  3. October 2026: New menopause treatment guidelines were issued by OB-GYN groups.

Health Landscape

The current strain on estradiol patch supplies follows the 2025 removal of the FDA black box warning, which significantly shifted clinical prescribing habits. This evolution marks a departure from the more restrictive treatment climate established by 2014 menopause guidelines.

If you are having trouble filling your prescription for estradiol patches, talk with your doctor about potential therapeutic equivalents like oral tablets or topical creams. It is also worth calling multiple pharmacies in your area, as supply levels can vary significantly between individual locations.

The takeaway

While demand for estradiol patches remains high, the product is not officially listed as in shortage. If your pharmacy is out of stock, discuss timing and alternative estrogen delivery methods with your physician before switching treatments.

Further reading

For more on managing hormone therapy, visit Women’s Health.

More information

Track current availability updates on the national drug shortage list.

Source note: This article includes information reported by KSL.

Live Poll

Do you feel confident that you can consistently access your necessary prescription medications?